What should be monitored on postoperative day 1 after transcatheter aortic valve replacement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Postoperative Day 1 TAVR Monitoring

On POD 1 after TAVR, you must monitor telemetry and vital signs continuously, perform frequent neurological assessments, closely observe the access site for bleeding/hematoma/pseudoaneurysm, track intake/output, obtain laboratory results (CBC and metabolic panel), ensure early mobilization, and obtain a predischarge ECG and echocardiogram. 1

Critical Monitoring Parameters

Cardiac Monitoring

  • Continuous telemetry per hospital protocol for arrhythmias, particularly atrial fibrillation (most common early complication after valve replacement) and conduction abnormalities 1
  • Vital signs monitoring including blood pressure and heart rate 1
  • Monitor for signs of cardiac conduction defects and heart block, which are key complications requiring surveillance 1

Neurological Assessment

  • Frequent neurological assessments to detect stroke or transient ischemic events early 1
  • Monitor mental status continuously 1

Access Site Surveillance

  • Monitor access site (groin or thorax depending on approach) for:
    • Bleeding
    • Hematoma formation
    • Pseudoaneurysm 1
  • Perform ultrasound of groin site if concern for pseudoaneurysm develops 1

Laboratory Monitoring

  • CBC to assess for bleeding complications 1
  • Metabolic panel (M6) to monitor renal function and electrolytes 1

Volume Status

  • Monitor intake and output closely to assess fluid balance 1

Essential Predischarge Testing

Imaging Studies

  • Predischarge echocardiogram to establish baseline valve function and assess for:

    • Paravalvular regurgitation
    • Central valve regurgitation
    • New pericardial effusion
    • Changes in mitral valve or left ventricular function 1
  • Predischarge ECG to document rhythm and conduction status 1

Clinical Management

Pain and Mobility

  • Provide appropriate pain management while maintaining mental status monitoring 1
  • Mobilize as soon as access site allows - this is critical for elderly patients with high comorbidity burden 1
  • Encourage physical activity early 1

Comorbidity Management

  • Resume preoperative medications promptly after review 1
  • Manage concurrent comorbidities actively 1

Functional Assessment

  • Physical therapy (PT) and occupational therapy (OT) assessment to determine appropriate disposition 1

Common Pitfalls to Avoid

Delayed recognition of conduction abnormalities: Heart block can develop hours to days after TAVR due to mechanical trauma from valve deployment. Continuous telemetry is non-negotiable on POD 1.

Missed access site complications: Pseudoaneurysms may not be immediately apparent. Have a low threshold for ultrasound evaluation if there is any concern about the access site.

Inadequate neurological monitoring: Stroke is a devastating complication. Frequent, structured neurological checks (not just "alert and oriented") are essential.

Premature mobilization before access site stability: While early mobilization is encouraged, ensure hemostasis is adequate at the access site first to prevent bleeding complications.

Overlooking volume status: These patients often have heart failure and renal dysfunction. Careful fluid balance monitoring prevents both volume overload and acute kidney injury.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.